Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.01
-0.01-0.98%
At close: -
$0.9999
-0.01-1.00%
After Hours: Jun 27, 7:59 PM EDT
Comments
Loading...
Iterum Therapeutics Analyst Ratings and Price Targets | NASDAQ:ITRM | Benzinga
Iterum Therapeutics PLC has a consensus price target of $7 based on the ratings of 2 analysts. The high is $9 issued by HC Wainwright & Co. on May 8, 2025. The low is $5 issued by HC Wainwright & Co. on September 10, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 8, 2025, September 10, 2024, and August 15, 2024, respectively. With an average price target of $6.33 between HC Wainwright & Co., there's an implied 533.40% upside for Iterum Therapeutics PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Iterum Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2025 | Buy Now | 800.09% | HC Wainwright & Co. | Joseph Pantginis47% | → $9 | Assumes | → Buy | Get Alert |
| 09/10/2024 | Buy Now | 400.05% | HC Wainwright & Co. | Ed Arce66% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2024 | Buy Now | 400.05% | HC Wainwright & Co. | Ed Arce66% | $6 → $5 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/31/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 04/30/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 02/07/2024 | Buy Now | 500.06% | HC Wainwright & Co. | Ed Arce66% | $6 → $6 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for Iterum Therapeutics (ITRM) stock?
The latest price target for Iterum Therapeutics (NASDAQ:ITRM) was reported by HC Wainwright & Co. on May 8, 2025. The analyst firm set a price target for $9.00 expecting ITRM to rise to within 12 months (a possible 800.09% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Iterum Therapeutics (ITRM)?
The latest analyst rating for Iterum Therapeutics (NASDAQ:ITRM) was provided by HC Wainwright & Co., and Iterum Therapeutics their buy rating.
When was the last upgrade for Iterum Therapeutics (ITRM)?
The last upgrade for Iterum Therapeutics PLC happened on February 7, 2024 when HC Wainwright & Co. raised their price target to $6. HC Wainwright & Co. previously had a neutral for Iterum Therapeutics PLC.
When was the last downgrade for Iterum Therapeutics (ITRM)?
There is no last downgrade for Iterum Therapeutics.
When is the next analyst rating going to be posted or updated for Iterum Therapeutics (ITRM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Iterum Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Iterum Therapeutics was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
Is the Analyst Rating Iterum Therapeutics (ITRM) correct?
While ratings are subjective and will change, the latest Iterum Therapeutics (ITRM) rating was a with a price target of $0.00 to $9.00. The current price Iterum Therapeutics (ITRM) is trading at is $1.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
